Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current COVID-19 disease pandemic. In some patients, the symptoms are mild, and a fraction of SARS-CoV-2-infected individuals develop severe illness with a high fatality rate due to lung damage and acute respiratory distress syndrome. 1

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Eosinophilic Esophagitis
• Share to IL-33, ST2, and ILC Pathways
• Share to Immune Cell Function and Interaction